Partnership announced between Canopy Biosciences – A Bruker Company – and Navinci Diagnostics AB We are pleased to announce that Navinci’s innovative in situ proximity ligation technology can now be offered by Canopy Biosciences as part of their CRO service lab, enabling more researchers than ever to visualise and quantify proteins, protein-protein interactions and post-translational modifications in situ. […]
Shimadzu Corporation has invested in Symbiobe Inc. (Symbiobe), through its Corporate Venture Capital (CVC) fund, “Shimadzu Future Innovation Fund” (Shimadzu FIF). Symbiobe is a startup originating from Kyoto University that develops carbon dioxide and nitrogen fixation technology using photosynthetic organisms*. Founded in 2021, Symbiobe aims to solve social issues such as climate change and resource […]
Cellares and Sony will collaborate on integrating Sony’s cell sorting and analytical technologies into the Cell Shuttle, Cellares’ automated cell therapy manufacturing platform Integration of this technology will enable the Cell Shuttle to efficiently automate the manufacture of sorting-dependent modalities such as regulatory T cell therapies (Tregs) and hematopoietic stem cell therapies (HSCs) Additionally, this […]
Advancing structural biology research with the GenNext AutoFox® Protein Footprinting System and Agilent 6560 Ion Mobility Quadrupole Time-of-Flight (IM-QTOF) LC/MS system Caption: GenNext and Agilent announced a pioneering collaboration for structural biology research. Half Moon Bay, CA – Today at CASSSS 2024, GenNext Technologies and Agilent announced a pioneering collaboration that promises to transform structural […]
Shimadzu Corporation, DKS Co., Ltd. (Kyoto City, hereinafter DKS), and Professor Shigeo Horie of Graduate School of Medicine, Juntendo University signed a technical partnership agreement regarding techniques used to identify functional properties of biologically active substances contained in foods and pharmaceuticals. The technical partnership will research Cordyceps sinensis, a “caterpillar fungus” obtained using a proprietary […]
In 2024, Shimadzu Corporation started SPARK* (hereinafter, “this system”), a system to support employees acquiring doctorates by encouraging both their doctoral studies and routine work activities. This system supports the acquisition of university degrees by those interested in obtaining a doctorate where their domain of research from a work strategy perspective fits with the theme of […]
DKSH has formed a strategic partnership with NanoCellect Biomedical, a manufacturer of unique cartridge-based cell sorters and image-guided cell analyzers and sorters. DKSH will leverage its expertise and global experience to enhance NanoCellect’s business opportunities in six new markets in Southeast Asia. Bangkok – DKSH Business Unit Technology has formed a partnership with NanoCellect Biomedical, […]
SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing
The companies commit to bring cutting-edge liquid biopsy testing to 20 institutions globally over the next 12 months BOSTON and ROLLE, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced a new milestone in the global introduction of the liquid biopsy test MSK-ACCESS® powered with SOPHiA DDM™, first announced […]
MGI also launched a new AI tool “αLab Studio” and announced collaborations with six top research institutes and enterprises in Hong Kong Science Park Hong Kong – MGI (MGI Tech Co., Ltd. and its subsidiaries, collectively referred to as MGI), a company committed to building core tools and technologies that drive innovation in life science, today announced […]
Partnership aims to make liquid biopsy tumor profiling more accessible to local laboratories, clinicians and patients through rapid, affordable, kitted NGS testing solutions. Natick, MA – Pillar Biosciences, Inc., has entered into a strategic partnership with AstraZeneca to expand laboratory access to molecular testing, using rapid, Next Generation Sequencing (NGS)-based liquid biopsy tumor profiling panels for […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
